English – Page 57 – TechStock²

Caris Life Sciences (CAI) stock drops on preliminary 2025 results, Everlywell cancer-screening deal

NEW YORK, Jan 12, 2026, 15:29 (EST) — Trading in the regular session. Caris Life Sciences shares dropped roughly 8.5% to $26.08 in afternoon trading, after fluctuating between $25.35 and $29.77 earlier today. The update comes amid J.P. Morgan Healthcare

12 January 2026

Biotechnology·Financial News·Healthcare Industry·Stock Market

HealthEquity stock slides nearly 10% after 2027 outlook; JPM conference is next test

New York, Jan 12, 2026, 15:31 EST — Regular session Shares of HealthEquity dropped roughly 10% in Monday afternoon trading following the benefits administrator’s cautious initial fiscal 2027 outlook. The stock last traded down $9.53 at $84.62, hitting a session

12 January 2026

Earnings Reports·Financial News·Investment Analysis·Stock Market

Credo Technology (CRDO) stock climbs as AI-chip trade stays hot; Needham conference next

NEW YORK, Jan 12, 2026, 15:19 EST — Regular session Shares of Credo Technology Group Holding Ltd climbed 3.1% to $155.10 in Monday afternoon trading, bouncing between $145.35 and $156.43 earlier. The Nasdaq-listed company, with a market cap near $32.5

12 January 2026

Artificial Intelligence·Financial News·Investing·Stock Market·Technology

Synchrony Financial stock slides on Trump’s 10% credit-card rate cap pitch — what investors watch next

New York, Jan 12, 2026, 3:33 PM EST — Regular session Shares of Synchrony Financial dropped sharply on Monday, tumbling 8.2% to $79.76 in afternoon trading. The slide followed President Donald Trump’s push for a one-year cap on credit-card interest

12 January 2026

Economic Policy·Financial News·Investment Strategies·Stock Market

Mesoblast (MESO) stock drops 11% as traders digest insider buy and Ryoncil sales backdrop

New York, Jan 12, 2026, 15:14 (EST) — Regular session Mesoblast Ltd’s shares on the U.S. market dropped roughly 11% Monday, sliding to $18.64 in afternoon trading after hitting $20.14 earlier. The Australian biotech’s stock has seen sharp swings since

12 January 2026

Biotech Industry·Insider Trading·Investment Insights·Stock Market News

Texas Instruments stock slips as chip ETF firms; investors eye Jan. 27 earnings amid Fed jitters

New York, Jan 12, 2026, 15:11 EST — Regular session. Texas Instruments shares slipped slightly on Monday afternoon, lagging behind the steadier semiconductor sector. The stock dipped roughly 0.2% to $189.85. The split matters since Texas Instruments serves as a

12 January 2026

Earnings Reports·Federal Reserve·Investment Analysis·Semiconductors·Stock Market

Summit Therapeutics stock tumbles as FDA filing for ivonescimab hits tape, GSK trial tie-up follows

New York, Jan 12, 2026, 14:55 EST — Regular session Shares of Summit Therapeutics Inc dropped roughly 11% to $17.46 Monday afternoon, after fluctuating between $20.30 and $16.51. The move came following the company’s announcement that it filed a U.S.

12 January 2026

Biotech·Clinical Trials·FDA Approvals·Healthcare News

Nebius stock jumps nearly 10% in regular trading as AI-cloud names catch a bid

New York, Jan 12, 2026, 15:05 ET — Regular session Nebius Group N.V. shares surged close to 10% Monday afternoon, riding the tailwind from a tech sector rally as investors shifted focus back to AI infrastructure names. This shift is

12 January 2026

AI·Cloud Computing·Financial News·Stock Market·Technology Stocks

Figure Technology Solutions stock drops nearly 10% after FIGR posts preliminary Q4 loan data

New York, Jan 12, 2026, 15:09 EST — Regular session Shares of Figure Technology Solutions, Inc. dropped steeply on Monday following the release of preliminary Q4 operating data, offering a first glimpse into its loan marketplace and crypto-related offerings. The

12 January 2026

Company Earnings·Financial News·Investments·Stock Market·Technology

Bread Financial (BFH) stock slides on Trump’s 10% credit-card rate cap push; what’s next

New York, Jan 12, 2026, 15:08 EST — Regular session Bread Financial Holdings’ shares dropped 10.8% to $71.65 in afternoon trading Monday, hitting a low of $70.06 earlier in the session. The move came after President Donald Trump proposed capping

12 January 2026

Economic Policy·Financial News·Interest Rates·Stock Market

Lululemon stock rises after holiday-quarter outlook shifts to high end as LULU investors eye ICR

NEW YORK, Jan 12, 2026, 15:12 EST — Regular session Shares of lululemon athletica inc climbed roughly 3.2% to $210.43 Monday afternoon. The boost came after the company forecasted its fourth-quarter revenue and profit to hit the upper end of

12 January 2026

Earnings Reports·Financial Analysis·Investor News·Retail Industry·Stock Market

GeneDx (WGS) stock dives on 2026 guidance despite strong 2025 prelims — what to watch next

New York, Jan 12, 2026, 2:46 PM EST — Regular session Shares of GeneDx Holdings Corp dropped roughly 14% Monday following the release of its 2026 outlook and preliminary results for 2025. The stock slipped $19.64 to trade at $115.75

12 January 2026

Biotechnology·Financial Analysis·Investment·Stock Market